Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMC trial in Major Depressive Disorder
DRKS00000320Phase 4Completed
- Sponsor
- University Medical Center Mainz
- Start
- Jan 2010
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram, venlafaxine, lithium in major depressive disorder (MDD), major depressive episode (MDE), recurrent depressive disorder (RDD), sponsored by University Medical Center Mainz. Started Jan 2010; status: completed.
02
Drugs
escitalopramvenlafaxinelithium
03
Conditions
major depressive disorder (MDD)major depressive episode (MDE)recurrent depressive disorder (RDD)
Beyond the preview
Go deeper on DRKS00000320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000320.